$14.27
0.171.21%
Last update: Nov 6, 4:01 PM
Mesoblast Ltd
MESONASDAQ
The average analyst price target for Mesoblast is $25.50, 78.7% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $12 to $39. The latest change came on Aug 27, 2026, when Piper Sandler raised its price target on Mesoblast from $35 to $39 and kept an Overweight rating.
Price Target Range — 4 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
